Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P David

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of Personalized Medicine|July 27, 2022
Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare SystemLoren Saulsberry, Lavisha Singh, Jaclyn Pruitt, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 12, 2003
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?Sean P David, Raymond Niaura, George D Papandonatos, et al.
BMJ Open|July 1, 2016
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalenceTeresa M Leyro, Erin E Crew, Susan W Bryson, et al.
Contemporary Clinical Trials|February 4, 2014
Teaching tobacco dependence treatment and counseling skills during medical school: rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trialRashelle B Hayes, Alan Geller, Linda Churchill, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 13, 2017
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and HowLi-Shiun Chen, Laurie Zawertailo, Thomas M Piasecki, et al.
Journal of Community Genetics|December 28, 2017
Patient and provider perspectives on the development of personalized medicine: a mixed-methods approachLauren Puryear, Natalie Downs, Andrea Nevedal, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2017
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic FindingsNancy L Saccone, James W Baurley, Andrew W Bergen, et al.
Menopause (New York, N.Y.)|July 25, 2013
No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal womenMichael N Passarelli, Polly A Newcomb, Karen W Makar, et al.
Pharmacogenomics|June 20, 2018
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessationNaji C Salloum, Erica L F Buchalter, Swati Chanani, et al.
Preventive Medicine|January 10, 2015
Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical studentsRashelle B Hayes, Alan C Geller, Sybil L Crawford, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Personalized Medicine|July 27, 2022
Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare SystemLoren Saulsberry, Lavisha Singh, Jaclyn Pruitt, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 12, 2003
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?Sean P David, Raymond Niaura, George D Papandonatos, et al.
BMJ Open|July 1, 2016
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalenceTeresa M Leyro, Erin E Crew, Susan W Bryson, et al.
Contemporary Clinical Trials|February 4, 2014
Teaching tobacco dependence treatment and counseling skills during medical school: rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trialRashelle B Hayes, Alan Geller, Linda Churchill, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 13, 2017
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and HowLi-Shiun Chen, Laurie Zawertailo, Thomas M Piasecki, et al.
Journal of Community Genetics|December 28, 2017
Patient and provider perspectives on the development of personalized medicine: a mixed-methods approachLauren Puryear, Natalie Downs, Andrea Nevedal, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2017
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic FindingsNancy L Saccone, James W Baurley, Andrew W Bergen, et al.
Menopause (New York, N.Y.)|July 25, 2013
No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal womenMichael N Passarelli, Polly A Newcomb, Karen W Makar, et al.
Pharmacogenomics|June 20, 2018
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessationNaji C Salloum, Erica L F Buchalter, Swati Chanani, et al.
Preventive Medicine|January 10, 2015
Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical studentsRashelle B Hayes, Alan C Geller, Sybil L Crawford, et al.
Pageof 10